Stay updated on Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision history updated with entries on 2026-04-13, 2026-04-09, and 2026-04; version updated from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-16T11:47:55.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Site-wide release notes indicate a software version update to Revision: v3.5.0 with March 2026 dates, replacing the previous Revision: v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-18T21:04:50.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed as a topic, and MedlinePlus Genetics is added under related topics. The site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-11T17:41:25.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Related topic links for 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the related topics section.
    Difference
    0.1%
    Check dated 2026-02-25T09:01:08.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Updated the page metadata to include related topics for Multiple Myeloma and MedlinePlus Genetics and adjusted date-stamped entries (2026-02-12, 2026-02-13) while removing older timestamps (2026-01-16, 2026-01-15, 2026-01). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-18T04:19:18.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the older Revision: v3.4.1, the government funding status notice, and related topic references (Multiple myeloma and MedlinePlus Genetics).
    Difference
    0.5%
    Check dated 2026-02-11T02:24:52.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page.